IL127350A0 - Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV - Google Patents
Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIVInfo
- Publication number
- IL127350A0 IL127350A0 IL12735097A IL12735097A IL127350A0 IL 127350 A0 IL127350 A0 IL 127350A0 IL 12735097 A IL12735097 A IL 12735097A IL 12735097 A IL12735097 A IL 12735097A IL 127350 A0 IL127350 A0 IL 127350A0
- Authority
- IL
- Israel
- Prior art keywords
- zidovudine
- hiv
- combinations
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2217896P | 1996-06-25 | 1996-06-25 | |
| GBGB9614024.9A GB9614024D0 (en) | 1996-07-04 | 1996-07-04 | Antiviral therapeutic combinations |
| PCT/EP1997/003246 WO1997049410A1 (en) | 1996-06-25 | 1997-06-23 | Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL127350A0 true IL127350A0 (en) | 1999-10-28 |
Family
ID=26309631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12735097A IL127350A0 (en) | 1996-06-25 | 1997-06-23 | Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6486136B1 (es) |
| EP (1) | EP0910386B1 (es) |
| KR (1) | KR20000022225A (es) |
| CN (1) | CN1306430A (es) |
| AP (1) | AP9801418A0 (es) |
| AT (1) | ATE230267T1 (es) |
| AU (1) | AU723877C (es) |
| BR (1) | BR9709951A (es) |
| CA (1) | CA2262765A1 (es) |
| CO (1) | CO4910137A1 (es) |
| CZ (1) | CZ429398A3 (es) |
| DE (1) | DE69718168T2 (es) |
| EA (1) | EA001457B1 (es) |
| ES (1) | ES2189964T3 (es) |
| HU (1) | HUP9903098A3 (es) |
| ID (1) | ID18739A (es) |
| IL (1) | IL127350A0 (es) |
| IS (1) | IS4913A (es) |
| NO (1) | NO986035L (es) |
| NZ (1) | NZ333098A (es) |
| PE (1) | PE87398A1 (es) |
| PL (1) | PL330791A1 (es) |
| TR (1) | TR199802703T2 (es) |
| WO (1) | WO1997049410A1 (es) |
| YU (1) | YU58498A (es) |
| ZA (1) | ZA975565B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9709945D0 (en) | 1997-05-17 | 1997-07-09 | Glaxo Group Ltd | A novel salt |
| NZ500868A (en) * | 1997-05-17 | 2001-08-31 | Glaxo Group Ltd | Antiviral combinations comprising 1592U89 and HIV protease inhibitors |
| GB9802472D0 (en) * | 1998-02-06 | 1998-04-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| BR9911457A (pt) * | 1998-06-24 | 2001-12-11 | Univ Emory | Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
| MY104575A (en) | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
| GB9307013D0 (en) * | 1993-04-02 | 1993-05-26 | Wellcome Found | Therapeutic combinations |
| US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| UA49803C2 (uk) | 1994-06-03 | 2002-10-15 | Дж.Д. Сьорль Енд Ко | Спосіб лікування ретровірусних інфекцій |
| US5646180A (en) * | 1995-12-05 | 1997-07-08 | Vertex Pharmaceuticals Incorporated | Treatment of the CNS effects of HIV |
-
1997
- 1997-06-23 CZ CZ984293A patent/CZ429398A3/cs unknown
- 1997-06-23 TR TR1998/02703T patent/TR199802703T2/xx unknown
- 1997-06-23 KR KR1019980710645A patent/KR20000022225A/ko not_active Application Discontinuation
- 1997-06-23 WO PCT/EP1997/003246 patent/WO1997049410A1/en active Search and Examination
- 1997-06-23 DE DE69718168T patent/DE69718168T2/de not_active Expired - Fee Related
- 1997-06-23 US US09/202,674 patent/US6486136B1/en not_active Expired - Fee Related
- 1997-06-23 HU HU9903098A patent/HUP9903098A3/hu unknown
- 1997-06-23 ES ES97928262T patent/ES2189964T3/es not_active Expired - Lifetime
- 1997-06-23 CA CA002262765A patent/CA2262765A1/en not_active Abandoned
- 1997-06-23 AP APAP/P/1998/001418A patent/AP9801418A0/en unknown
- 1997-06-23 ID IDP972146A patent/ID18739A/id unknown
- 1997-06-23 CN CN97197356A patent/CN1306430A/zh active Pending
- 1997-06-23 EP EP97928262A patent/EP0910386B1/en not_active Expired - Lifetime
- 1997-06-23 IL IL12735097A patent/IL127350A0/xx unknown
- 1997-06-23 CO CO97034780A patent/CO4910137A1/es unknown
- 1997-06-23 AT AT97928262T patent/ATE230267T1/de not_active IP Right Cessation
- 1997-06-23 ZA ZA975565A patent/ZA975565B/xx unknown
- 1997-06-23 PL PL97330791A patent/PL330791A1/xx unknown
- 1997-06-23 AU AU32626/97A patent/AU723877C/en not_active Ceased
- 1997-06-23 PE PE1997000535A patent/PE87398A1/es not_active Application Discontinuation
- 1997-06-23 EA EA199801046A patent/EA001457B1/ru not_active IP Right Cessation
- 1997-06-23 BR BR9709951A patent/BR9709951A/pt not_active IP Right Cessation
-
1998
- 1998-11-30 IS IS4913A patent/IS4913A/is unknown
- 1998-12-16 YU YU58498A patent/YU58498A/sr unknown
- 1998-12-18 NZ NZ333098A patent/NZ333098A/en unknown
- 1998-12-22 NO NO986035A patent/NO986035L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1306430A (zh) | 2001-08-01 |
| DE69718168D1 (de) | 2003-02-06 |
| AU3262697A (en) | 1998-01-14 |
| ID18739A (id) | 1998-05-07 |
| AP9801418A0 (en) | 1998-12-31 |
| HUP9903098A3 (en) | 2000-01-28 |
| DE69718168T2 (de) | 2003-10-23 |
| EA199801046A1 (ru) | 1999-08-26 |
| HUP9903098A2 (hu) | 1999-12-28 |
| AU723877B2 (en) | 2000-09-07 |
| CA2262765A1 (en) | 1997-12-31 |
| AU723877C (en) | 2001-08-23 |
| BR9709951A (pt) | 1999-08-10 |
| PE87398A1 (es) | 1999-01-15 |
| ATE230267T1 (de) | 2003-01-15 |
| US6486136B1 (en) | 2002-11-26 |
| NO986035D0 (no) | 1998-12-22 |
| CZ429398A3 (cs) | 1999-05-12 |
| HU9903098D0 (en) | 1999-10-28 |
| YU58498A (en) | 1999-11-22 |
| NO986035L (no) | 1999-02-23 |
| WO1997049410A1 (en) | 1997-12-31 |
| KR20000022225A (ko) | 2000-04-25 |
| EP0910386A1 (en) | 1999-04-28 |
| ES2189964T3 (es) | 2003-07-16 |
| ZA975565B (en) | 1998-12-23 |
| IS4913A (is) | 1998-11-30 |
| NZ333098A (en) | 2000-08-25 |
| TR199802703T2 (xx) | 1999-03-22 |
| EA001457B1 (ru) | 2001-04-23 |
| EP0910386B1 (en) | 2003-01-02 |
| CO4910137A1 (es) | 2000-04-24 |
| PL330791A1 (en) | 1999-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL125981A0 (en) | Improved tissue destruction in cryosurgery | |
| HK1105580A1 (en) | Use of isoflavone compounds in the manufacture of medicament and composition comprising the same | |
| HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
| IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
| HUP9904047A3 (en) | N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds | |
| HK1020259A1 (en) | Composition for use in the treatment and prevention of hyperuricemia. | |
| AU7597898A (en) | Use of isoflavonoids in the treatment or prevention of postpartum depression | |
| IL127351A0 (en) | Combinations comprising VX478 zidovudine FTC and/or 3TC for use in the treatment of HIV | |
| GB2317182B (en) | Sulfated polysaccharides and uses thereof in medical treatment | |
| ZA97741B (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders. | |
| ZA975288B (en) | The use of TCET in the prophylaxis and treatment of allergies. | |
| HK1018271A1 (en) | Substituted benzylamines and their use for the treatment of depression | |
| AU2418499A (en) | Org-5222 in the treatment of depression | |
| GB9419553D0 (en) | Polypeptides and their use in the treatment of auto-immune disease | |
| IL127350A0 (en) | Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV | |
| ZA959904B (en) | Iminooxymethyleneanilides thei preparation and their use | |
| HUP9902802A3 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders | |
| GB2321644B (en) | Cosmetic composition for the treatment of the hair and/or the body | |
| AU3061199A (en) | Skin treatment compositions and the use thereof | |
| AU2705495A (en) | Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory | |
| EP1032266A4 (en) | USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS | |
| AU5871898A (en) | Microparticles and their use in cancer treatment | |
| AU2713797A (en) | Depigmentating agent in the treatment of melasma | |
| IL109356A0 (en) | N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones | |
| IL127040A0 (en) | Use of substituted azaspirane in the treatment of asthma |